IP Library Granted Patent US 7,973,176
Granted Patent B2
US 7,973,176 · App. 11/990,766 · Granted Jul 5, 2011

Process for production of aralkyloxypyrrolidine derivative

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,973,176
App. No.
11/990,766
Granted
Jul 5, 2011
Kind
B2
Abstract

The present invention provides a process for producing a 3-aralkyloxypyrrolidine derivative which is important for production of pharmaceutical products and the like. In the present invention, a N-protected-3-hydroxypyrrolidine is converted into a N-protected-3-aralkyloxypyrrolidine by allowing an aralkyl halide to act in the presence of a base and at least one of a metal halide and a phase-transfer catalyst followed by deprotecting a N-protecting group to convert it to a 3-aralkyloxypyrrolidine derivative and subsequently treating the derivative in a solvent containing a polar solvent, thereby obtaining the 3-aralkyloxypyrrolidine derivative as a crystal. According to the present invention, a 3-aralkyloxypyrrolidine derivative of high purity can be produced conveniently and efficiently on an industrial scale.

Claims (18)

1. A process for producing a crystallized 3-aralkyloxypyrrolidine derivative (2) comprising subjecting a non-crystallized 3-aralkyloxypyrrolidine derivative (2) to a crystallization process using a solvent comprising a polar organic solvent to obtain the crystallized 3-aralkyloxypyrrolidine derivative (2),

wherein the 3-aralkyloxypyrrolidine derivative (2) is represented by the following formula (2):

wherein R represents a benzyl group; and HX represents a mineral acid, sulfonic acid, carboxylic acid or amino acid.

2. The process according to claim 1 , wherein the polar organic solvent is an ester solvent and/or an alcohol solvent.

3. The process according to claim 1 , wherein the crystallization process comprises adding a seed crystal.

4. The process according to claim 1 , further comprising, before the crystallization process, purifying the non-crystallized 3-aralkyloxypyrrolidine derivative (2) by a series of operations of:

A) treating an aqueous layer with a base after removing an organic layer from a two-phase mixture of water and an organic solvent containing a 3-aralkyloxypyrrolidine derivative (2);

B) extracting a free amine of the 3-aralkyloxypyrrolidine derivative (2) using an organic solvent; and

C) treating the free amine with an acid to convert the 3-aralkyloxypyrrolidine derivative (2) to the non-crystallized 3-aralkyloxypyrrolidine derivative (2).

5. The process according to claim 1 or 4 , wherein the non-crystallized 3-aralkyloxypyrrolidine derivative (2) is obtained by removing a N-protecting group of a N-protected-3-aralkyloxypyrrolidine (1) represented by formula (1);

wherein R represents a benzyl group; and P represents a protecting group of an amino group.

6. The process according to claim 5 , wherein the N-protected-3-aralkyloxypyrrolidine (1) is obtained by 0-aralkylation of a hydroxyl group of N-protected-3-hydroxypyrrolidine represented by formula (5);

wherein P represents a protecting group of an amino group.

7. The process according to claim 1 or 4 , wherein the non-crystallized 3-aralkyloxypyrrolidine derivative (2) is optically active.

8. The process according to claim 5 , wherein the N-protected-3-aralkyloxypyrrolidine (1) is one obtained by 0-aralkylation of a N-protected-3-hydroxypyrrolidine represented by formula (5) by allowing an aralkyl halide to act in the presence of a base and at least one of a metal halide and a phase-transfer catalyst:

wherein P represents a protecting group of an amino group.

9. The process according to claim 6 , wherein the pyrrolidine derivatives represented by the above formula (1) and (5) are optically active.

10. The process according to claim 1 , wherein the crystallized 3-aralkyloxypyrrolidine derivative (2) is optically active, and/or the non-crystallized 3-aralkyloxypyrrolidine derivative (2) is optically active.

Assignments (2)
CHANGE OF ADDRESS Recorded Jan 15, 2014
From: KANEKA CORPORATION
To: KANEKA CORPORATION
Reel/Frame 032019/0901 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 21, 2008
From: TAKEDA, TOSHIHIRO; OHNUKI, MASATOSHI; KISHIMOTO, NARUMI
To: KANEKA CORPORATION
Reel/Frame 020574/0866 →